Literature DB >> 34074938

The solid organ transplant recipient with SARS-CoV-2 infection.

Justin C Laracy1, Benjamin A Miko, Marcus R Pereira.   

Abstract

PURPOSE OF REVIEW: The COVID-19 pandemic is a major challenge to global health, particularly among vulnerable populations. Here, we describe the emerging epidemiology and relevant data on treatment options for COVID-19. We discuss the implications of current knowledge for solid organ transplant (SOT) recipients. RECENT
FINDINGS: Risk factors and outcomes of COVID-19 among SOT recipients remain uncertain, but recent data suggest similar outcomes to the general population. Case reports of donor-derived SARS-CoV-2 infection are emerging. Few studies on treatment of COVID-19 among SOT recipients are available, and therefore, general recommendations are similar to the general population. Vaccine efficacy in the SOT population is uncertain.
SUMMARY: COVID-19 remains a significant threat to SOT recipients and studies on treatment and prevention specific to this population are urgently needed. Although vaccines represent the greatest hope to control this pandemic, their efficacy in this immunocompromised population is uncertain.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34074938      PMCID: PMC9092951          DOI: 10.1097/MOT.0000000000000888

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.269


  43 in total

1.  Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.

Authors:  Brian J Boyarsky; William A Werbel; Robin K Avery; Aaron A R Tobian; Allan B Massie; Dorry L Segev; Jacqueline M Garonzik-Wang
Journal:  JAMA       Date:  2021-05-04       Impact factor: 56.272

Review 2.  Liver transplantation in the era of COVID-19.

Authors:  Mohamed El Kassas; Mohamed Alboraie; Amira Al Balakosy; Nermeen Abdeen; Shimaa Afify; Mohammad Abdalgaber; Ahmed F Sherief; Ahmad Madkour; Mohamed Abdellah Ahmed; Mohamed Eltabbakh; Mohamed Salaheldin; Mohamed-Naguib Wifi
Journal:  Arab J Gastroenterol       Date:  2020-05-12       Impact factor: 2.076

3.  Covid-19 and Kidney Transplantation.

Authors:  Enver Akalin; Yorg Azzi; Rachel Bartash; Harish Seethamraju; Michael Parides; Vagish Hemmige; Michael Ross; Stefanie Forest; Yitz D Goldstein; Maria Ajaimy; Luz Liriano-Ward; Cindy Pynadath; Pablo Loarte-Campos; Purna B Nandigam; Jay Graham; Marie Le; Juan Rocca; Milan Kinkhabwala
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

4.  Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.

Authors:  Timothy P Sheahan; Amy C Sims; Sarah R Leist; Alexandra Schäfer; John Won; Ariane J Brown; Stephanie A Montgomery; Alison Hogg; Darius Babusis; Michael O Clarke; Jamie E Spahn; Laura Bauer; Scott Sellers; Danielle Porter; Joy Y Feng; Tomas Cihlar; Robert Jordan; Mark R Denison; Ralph S Baric
Journal:  Nat Commun       Date:  2020-01-10       Impact factor: 14.919

Review 5.  COVID-19 pandemic: Building organisational flexibility to scale transplant programs.

Authors:  Jeevan Prakash Gopal; Vassilios E Papalois
Journal:  World J Transplant       Date:  2020-10-18

6.  Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.

Authors:  Anthony C Gordon; Paul R Mouncey; Farah Al-Beidh; Kathryn M Rowan; Alistair D Nichol; Yaseen M Arabi; Djillali Annane; Abi Beane; Wilma van Bentum-Puijk; Lindsay R Berry; Zahra Bhimani; Marc J M Bonten; Charlotte A Bradbury; Frank M Brunkhorst; Adrian Buzgau; Allen C Cheng; Michelle A Detry; Eamon J Duffy; Lise J Estcourt; Mark Fitzgerald; Herman Goossens; Rashan Haniffa; Alisa M Higgins; Thomas E Hills; Christopher M Horvat; Francois Lamontagne; Patrick R Lawler; Helen L Leavis; Kelsey M Linstrum; Edward Litton; Elizabeth Lorenzi; John C Marshall; Florian B Mayr; Daniel F McAuley; Anna McGlothlin; Shay P McGuinness; Bryan J McVerry; Stephanie K Montgomery; Susan C Morpeth; Srinivas Murthy; Katrina Orr; Rachael L Parke; Jane C Parker; Asad E Patanwala; Ville Pettilä; Emma Rademaker; Marlene S Santos; Christina T Saunders; Christopher W Seymour; Manu Shankar-Hari; Wendy I Sligl; Alexis F Turgeon; Anne M Turner; Frank L van de Veerdonk; Ryan Zarychanski; Cameron Green; Roger J Lewis; Derek C Angus; Colin J McArthur; Scott Berry; Steve A Webb; Lennie P G Derde
Journal:  N Engl J Med       Date:  2021-02-25       Impact factor: 91.245

7.  Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Authors:  Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; Lily Y Weckx; Pedro M Folegatti; Parvinder K Aley; Brian Angus; Vicky L Baillie; Shaun L Barnabas; Qasim E Bhorat; Sagida Bibi; Carmen Briner; Paola Cicconi; Andrea M Collins; Rachel Colin-Jones; Clare L Cutland; Thomas C Darton; Keertan Dheda; Christopher J A Duncan; Katherine R W Emary; Katie J Ewer; Lee Fairlie; Saul N Faust; Shuo Feng; Daniela M Ferreira; Adam Finn; Anna L Goodman; Catherine M Green; Christopher A Green; Paul T Heath; Catherine Hill; Helen Hill; Ian Hirsch; Susanne H C Hodgson; Alane Izu; Susan Jackson; Daniel Jenkin; Carina C D Joe; Simon Kerridge; Anthonet Koen; Gaurav Kwatra; Rajeka Lazarus; Alison M Lawrie; Alice Lelliott; Vincenzo Libri; Patrick J Lillie; Raburn Mallory; Ana V A Mendes; Eveline P Milan; Angela M Minassian; Alastair McGregor; Hazel Morrison; Yama F Mujadidi; Anusha Nana; Peter J O'Reilly; Sherman D Padayachee; Ana Pittella; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Sarah Rhead; Alexandre V Schwarzbold; Nisha Singh; Andrew Smith; Rinn Song; Matthew D Snape; Eduardo Sprinz; Rebecca K Sutherland; Richard Tarrant; Emma C Thomson; M Estée Török; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Marion E E Watson; Christopher J Williams; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-12-08       Impact factor: 79.321

8.  SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease.

Authors:  Pengfei Wang; Lihong Liu; Manoj S Nair; Michael T Yin; Yang Luo; Qian Wang; Ting Yuan; Kanako Mori; Axel Guzman Solis; Masahiro Yamashita; Ankur Garg; Lawrence J Purpura; Justin C Laracy; Jian Yu; Leemor Joshua-Tor; Joseph Sodroski; Yaoxing Huang; David D Ho
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163

9.  Earliest cases of coronavirus disease 2019 (COVID-19) identified in solid organ transplant recipients in the United States.

Authors:  Olivia S Kates; Cynthia E Fisher; Helen C Stankiewicz-Karita; Amanda K Shepherd; E Chandler Church; Siddhartha G Kapnadak; Erika D Lease; Francis X Riedo; Robert M Rakita; Ajit P Limaye
Journal:  Am J Transplant       Date:  2020-05-08       Impact factor: 9.369

10.  COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients.

Authors:  Rebecca Craig-Schapiro; Thalia Salinas; Michelle Lubetzky; Brittany T Abel; Samuel Sultan; John R Lee; Sandip Kapur; Meredith J Aull; Darshana M Dadhania
Journal:  Am J Transplant       Date:  2020-11-08       Impact factor: 9.369

View more
  1 in total

Review 1.  Solid organ transplantations and COVID-19 disease.

Authors:  Emine Aylin Yılmaz; Öner Özdemir
Journal:  World J Transplant       Date:  2021-12-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.